Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
Successful test of cancer-killing ‘Trojan Horse’ drug marks ‘important advance’
Researchers have successfully tested a “Trojan Horse” drug which can kill cancer and bacterial cells without damaging nearby healthy tissue.
Experimental Treatment Offers New Hope Against Lupus
THURSDAY, May 27, 2021 (HealthDay News) -- An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests.
Vaccine protects against more HPV variants than previously known
The human papillomavirus (HPV) can cause cancer and many countries run national vaccination programs to minimize the risk.
FDA approves Bristol Myers’ Zeposia for UC
The US Food and Drug Administration yesterday approved Bristol Myers Squibb’s (NYSE.
Expert reaction to one-dose Janssen COVID-19 vaccine being approved by the MHRA
Is has been announced that the one-dose Janssen COVID-19 vaccine has today been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).
Inflammatory drug could prevent severe complications from COVID-19
The COLCORONA clinical study into using the inexpensive anti-inflammatory drug colchicine to treat COVID-19 was published today in the British journal The Lancet Respiratory Medicine, four months afte...
With latest FDA nod, Biohaven's Nurtec becomes first migraine med to prevent—and treat—attacks
The FDA approved Biohaven Pharmaceuticals’ oral Nurtec ODT to help prevent migraines.
Teva launches first DTC for Austedo into competitive tardive dyskinesia 2-drug market
Teva's first DTC campaign for tardive dyskinesia (TD) drug Austedo launches into a suddenly competitive TV ad space for the rare condition.
FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19
Today, the U.
EC approves Ponvory for relapsing MS
The European Commission (EC) has cleared Janssen’s Ponvory for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease.
Janssen’s Erleada maintains quality of life for prostate cancer patients
Janssen’s Erleada in addition to androgen deprivation therapy (ADT) maintained prostate cancer patients’ health-related quality of life (HRQoL), according to new patient-reported o...
The E.U. may seek billions in penalties if AstraZeneca’s vaccine deliveries fall short
Lawyers representing the European Union said on Wednesday that they would seek penalties from AstraZeneca that could run into the billions of euros if the pharmaceutical company fails to deliver tens ...
41
42
43
44
45
46
47
48
49
